Medical Condition News

RSS

Mitotane’s role in the management of adrenocortical carcinoma

Adrenocortical carcinoma (ACC) is a rare but aggressive malignancy with high postoperative recurrence rates and poor prognosis. Mitotane remains the only approved agent for ACC, exerting antitumor effects by disrupting mitochondrial integrity, inhibiting steroidogenic enzymes, and interfering with cholesterol metabolism.

21 Jan 2026

A dual-action approach to preventing hepatocellular carcinoma

Hepatocellular carcinoma is one of the leading causes of cancer-related death worldwide, largely due to its high rate of recurrence after surgery. Even after complete tumor removal, microscopic residual disease and early dissemination frequently lead to relapse within the first two years.

21 Jan 2026

Medicaid tries new approach with sickle cell: Companies get paid only if costly gene therapies work

Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting friends.

21 Jan 2026

Evidence shows no autism risk from paracetamol in pregnancy

Evidence from a comprehensive review shows no link between paracetamol in pregnancy and neurodevelopmental issues, supporting its safe use for pain management.

21 Jan 2026

UT Southwestern performs first regional whole-liver chemotherapy for rare eye cancer

A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic uveal melanoma, a rare and deadly eye cancer.

21 Jan 2026

Arthritis significantly restricts employment for millions of American adults

According to new research from the University of Delaware, nearly 40% of American adults ages 18 to 64 with arthritis - almost 10 million people - say the medical condition is limiting their ability to work.

21 Jan 2026

Rice’s SynthX Center leads interdisciplinary effort to tackle rare lymphatic disorders

Rice University's SynthX Center, directed by Han Xiao, has received an up to five-year, $18 million award from the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics and pHenotyping Technologies (LIGHT) program to develop innovative solutions for lymphatic diseases.

20 Jan 2026

Weill Cornell Medicine receives ARPA-H award to advance lymphatic disease diagnosis

Weill Cornell Medicine has received a $5.2 million, initial two-year award from the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics, and pHenotyping Technologies (LIGHT) program to develop a comprehensive and innovative approach to diagnosing lymphatic disease.

20 Jan 2026

New oral contrast agent improves bowel disease detection on CT scans

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the University of California San Francisco, and Nextrast Inc. found that a new imaging oral agent, also known as a "contrast agent," helps radiologists better see bowel structures and disease in CT imaging when compared with the current oral contrast agents.

20 Jan 2026

New AI learning tool bridges communication gaps between autistic and neurotypical people

People with autism have brains that are wired differently. This can make them especially strong in some areas-such as noticing patterns, remembering details, or thinking logically-while making other things like social cues or changes in routine more challenging.

20 Jan 2026

Early treatment delays rheumatoid arthritis onset in high-risk individuals

Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with benefits also continuing well after treatment has stopped.

20 Jan 2026

Lifestyle prevention of diabetes may halve carbon footprint associated with treating complications

Preventing high blood glucose (pre-diabetes) from turning into type 2 diabetes with lifestyle changes could more than halve the carbon footprint associated with treating the complications of the disease, suggests a modelling study, published in the open access journal BMJ Open.

20 Jan 2026

UK glaucoma cases expected to rise sharply due to aging population

The number of people over 40 in the UK living with glaucoma-the leading cause of irreversible blindness worldwide-is already higher than expected and is projected to surge to more than 1.6 million by 2060, finds research published online in the British Journal of Ophthalmology.

20 Jan 2026

Early pregnancy sulfur dioxide exposure raises odds of congenital limb defects

Maternal exposure to sulfur dioxide during the first trimester was associated with higher odds of congenital limb defects in offspring in a large population-based cohort from Wuhan. Associations were strongest for polydactyly and limb shortening, while other major air pollutants showed no consistent links with overall risk.

20 Jan 2026

Blood lipid–hormone ratios predict future asthma attacks years in advance

This study shows that specific ratios of circulating sphingolipids to steroids can predict the risk of future asthma exacerbations over five years with high discriminatory performance. By integrating metabolomics with longitudinal medical records, the research highlights lipid–hormone pathway imbalance as a key driver of asthma instability.

20 Jan 2026

HonorHealth patient first in Arizona to receive new investigational treatment for ischemic stroke

A stroke patient at HonorHealth Research Institute is the first in Arizona to receive a new investigational treatment that targets platelets - rather than traditional clotting proteins - to help reopen blocked blood vessels in the brain.

20 Jan 2026

Customizable protein platforms offer new hope for cancer treatment

Precise methods for shredding or repairing and replacing specific cancer-causing proteins in a malignant cell, developed at the University of Massachusetts Amherst, could have applications beyond cancer to a wide range of immunological diseases, members of the interdisciplinary research team say.

20 Jan 2026

Medical Condition News

Mitotane’s role in the management of adrenocortical carcinoma

A dual-action approach to preventing hepatocellular carcinoma

Medicaid tries new approach with sickle cell: Companies get paid only if costly gene therapies work

Evidence shows no autism risk from paracetamol in pregnancy

UT Southwestern performs first regional whole-liver chemotherapy for rare eye cancer

Arthritis significantly restricts employment for millions of American adults

Rice’s SynthX Center leads interdisciplinary effort to tackle rare lymphatic disorders

Weill Cornell Medicine receives ARPA-H award to advance lymphatic disease diagnosis

New oral contrast agent improves bowel disease detection on CT scans

New AI learning tool bridges communication gaps between autistic and neurotypical people

Early treatment delays rheumatoid arthritis onset in high-risk individuals

Lifestyle prevention of diabetes may halve carbon footprint associated with treating complications

UK glaucoma cases expected to rise sharply due to aging population

Early pregnancy sulfur dioxide exposure raises odds of congenital limb defects

Blood lipid–hormone ratios predict future asthma attacks years in advance

HonorHealth patient first in Arizona to receive new investigational treatment for ischemic stroke

Customizable protein platforms offer new hope for cancer treatment

Bio-detection dogs can sniff out hemangiosarcoma

Prolonged exposure to air pollution linked to elevated risk for ALS

Atypical mutation offers clues to personalized pancreatic cancer treatment

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News